The potential impact of the Affordable Care Act and Medicaid expansion on reducing colorectal cancer screening disparities in African American males.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
11
2018
accepted:
10
12
2019
entrez:
25
1
2020
pubmed:
25
1
2020
medline:
21
4
2020
Statut:
epublish
Résumé
Few investigations have explored the potential impact of the Affordable Care Act on health disparity outcomes in states that chose to forgo Medicaid expansion. Filling this evidence gap is pressing as Congress grapples with controversial healthcare legislation that could phase out Medicaid expansion. Colorectal cancer (CRC) is a commonly diagnosed, preventable cancer in the US that disproportionately burdens African American men and has substantial potential to be impacted by improved healthcare insurance coverage. Our objective was to estimate the impact of the Affordable Care Act (increasing insurance through health exchanges alone or with Medicaid expansion) on colorectal cancer outcomes and economic costs among African American and White males in North Carolina (NC), a state that did not expand Medicaid. We used an individual-based simulation model to estimate the impact of ACA (increasing insurance through health exchanges alone or with Medicaid expansion) on three CRC outcomes (screening, stage-specific incidence, and deaths) and economic costs among African American and White males in NC who were age-eligible for screening (between ages 50 and 75) during the study period, years of 2013-2023. Health exchanges and Medicaid expansion improved simulated CRC outcomes overall, though the impact was more substantial among AAs. Relative to health exchanges alone, Medicaid expansion would prevent between 7.1 to 25.5 CRC cases and 4.1 to 16.4 per 100,000 CRC cases among AA and White males, respectively. Our findings suggest policies that expanding affordable, quality healthcare coverage could have a demonstrable, cost-saving impact while reducing cancer disparities.
Identifiants
pubmed: 31978084
doi: 10.1371/journal.pone.0226942
pii: PONE-D-18-33874
pmc: PMC6980570
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0226942Subventions
Organisme : NIDA NIH HHS
ID : K01 DA032611
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL138159
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016086
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U48 DP005017
Pays : United States
Déclaration de conflit d'intérêts
Stephanie Wheeler discloses that she received unrelated grant funding from Pfizer. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The other authors have declared that no competing interests exist.
Références
Prev Med. 2017 Aug;101:44-52
pubmed: 28506715
Aliment Pharmacol Ther. 2012 Jun;35(12):1467-73
pubmed: 22540887
Health Place. 2014 Sep;29:114-23
pubmed: 25063908
Ann Intern Med. 2013 Jul 2;159(1):13-20
pubmed: 23817700
CA Cancer J Clin. 2017 May 6;67(3):177-193
pubmed: 28248415
Med Decis Making. 2011 Jan-Feb;31(1):10-8
pubmed: 20484091
J Policy Anal Manage. ;36(1):178-210
pubmed: 27992151
J Gen Intern Med. 2016 Mar;31(3):315-20
pubmed: 26349953
Prev Chronic Dis. 2017 Feb 23;14:E18
pubmed: 28231042
Dig Dis Sci. 2015 Oct;60(10):2930-6
pubmed: 25902746
Methods Rep RTI Press. 2009 May 1;2009(10):905
pubmed: 20505787
N Engl J Med. 2013 Feb 7;368(6):496-9
pubmed: 23323866
Health Aff (Millwood). 2012 May;31(5):920-30
pubmed: 22566430
Comput Biomed Res. 1999 Feb;32(1):13-33
pubmed: 10066353
Gastrointest Endosc. 2009 Jul;70(1):96-108, 108.e1-24
pubmed: 19467539
JAMA. 2015 Jul 28;314(4):366-74
pubmed: 26219054
Dig Dis Sci. 2012 Feb;57(2):489-95
pubmed: 22052446
Rand Health Q. 2012 Mar 1;2(1):2
pubmed: 28083224
Cancer Causes Control. 2015 Nov;26(11):1653-60
pubmed: 26376891
CA Cancer J Clin. 2016 Jul;66(4):290-308
pubmed: 26910411
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344-50
pubmed: 26843520
Health Aff (Millwood). 2017 Dec;36(12):2151-2159
pubmed: 29200350
J Trauma Acute Care Surg. 2017 May;82(5):887-895
pubmed: 28431415
Prev Med Rep. 2016 Dec 07;6:9-16
pubmed: 28210537
Health Aff (Millwood). 2014 Jan;33(1):78-87
pubmed: 24395938
Health Serv Res. 2013 Apr;48(2 Pt 2):826-49
pubmed: 23398372
Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):1971-8
pubmed: 19567507
Cancer. 2015 Jul 1;121(13):2281-5
pubmed: 25763558